FIVE PRIME THERAPEUTICS INC - COM (FPRX)

CUSIP: 33830X104

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class
Equity / COM
Total 13F shares
25,061,140
Share change
-1,106,191
Total reported value
$1,256,048,109
Put/Call ratio
0%
Price per share
$50.11
Number of holders
172
Value change
-$57,391,418
Number of buys
67
Number of sells
90

Quarterly Holders Quick Answers

What is CUSIP 33830X104?
CUSIP 33830X104 identifies FPRX - FIVE PRIME THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FIVE PRIME THERAPEUTICS INC - COM (FPRX) as of Q4 2016

As of 31 Dec 2016, FIVE PRIME THERAPEUTICS INC - COM (FPRX) was held by 172 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 25,061,140 shares. The largest 10 holders included FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, ADAGE CAPITAL PARTNERS GP, L.L.C., BlackRock Fund Advisors, ACADIAN ASSET MANAGEMENT LLC, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, EVENTIDE ASSET MANAGEMENT, LLC, and BlackRock Institutional Trust Company, N.A.. This page lists 172 institutional shareholders reporting positions in this security for the Q4 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.